Mirae Asset Healthcare Fund -Regular Growth
₹41.7990
₹0.57 (-1.35%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹41.7990
₹0.57 (-1.35%)
29 May 2026
AMFI: 143785
Direct · Growth
₹₹47.1850
₹0.64 (-1.34%)
29 May 2026
AMFI: 143783
Regular · IDCW
₹₹24.6070
₹0.34 (-1.35%)
29 May 2026
AMFI: 143786
Direct · IDCW
₹₹28.4200
₹0.39 (-1.34%)
29 May 2026
AMFI: 143784
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹47,000
Invested
₹1,03,841
Value today
19.7%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹4,180
Value today
19.8%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹10L corpus with ₹5,000/month withdrawals since inception
Corpus is still growing despite monthly payouts
₹10,00,000
Initial corpus
₹4,70,000
Withdrawn
₹31,41,493
Corpus left
+₹26,11,493 net gain — withdrew ₹4,70,000 AND corpus grew
Plan your SWP with real NAV₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹24,33,496
Value today
-3.0%
vs lumpsum
Direct lumpsum would have beaten STP by 3.0% — but STP reduced timing risk
Model your own STP with real NAVBeat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹1,03,841
Benchmark
₹82,224
+₹21,617 extra wealth vs the benchmark index
Backtest this SIP yourself₹1 lakh on the worst crash day — 22 Mar 2020
Worst single-day Nifty drop during this fund's life
₹1,00,000
Invested
₹4,32,031
Value today
4.3×
Multiple
Staying invested through that crash turned ₹1L into ₹4,32,031 — a 4.3× return
Read: Staying invested through crashesDirect vs Regular — ₹500/month over 7 years
Expense ratio drag on your actual returns
Direct plan
₹91,838
Regular plan
₹85,923
Direct earns ₹5,915 more on a ₹42K investment — 2.01% extra return per year
Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.
Learn about Direct vs Regular plansFund Details
Risk Metrics
Trailing 1 year, annualised0.19
Sharpe Ratio
+0.08
Alpha
0.31
Beta
0.18
Sortino
15.57%
Std Dev
-16.09%
Max Drawdown
Portfolio Holdings
Top 34 holdings · as of Mar 2026
| Security | % NAV |
|---|---|
Sun Pharmaceutical Industries Ltd. INE044A01036 | 12.20% |
Divi's Laboratories Ltd. INE361B01024 | 7.93% |
Glenmark Pharmaceuticals Ltd. INE935A01035 | 6.94% |
JB Chemicals & Pharmaceuticals Ltd. INE572A01036 | 6.88% |
Apollo Hospitals Enterprise Ltd. INE437A01024 | 6.15% |
Lupin Ltd. INE326A01037 | 5.06% |
Aurobindo Pharma Ltd. INE406A01037 | 4.32% |
Dr. Reddy's Laboratories Ltd. INE089A01031 | 4.31% |
Fortis Healthcare Ltd. INE061F01013 | 3.73% |
Laurus Labs Ltd. INE947Q01028 | 3.56% |
Aster DM Healthcare Ltd. INE914M01019 | 3.44% |
Cipla Ltd. INE059A01026 | 3.37% |
IPCA Laboratories Ltd. INE571A01038 | 3.32% |
Krishna Institute of Medical Sciences Ltd. INE967H01025 | 3.26% |
Alkem Laboratories Ltd. INE540L01014 | 3.25% |
Sai Life Sciences Ltd. INE570L01029 | 3.03% |
Onesource Specialty Pharma Ltd. INE013P01021 | 2.91% |
Eris Lifesciences Ltd. INE406M01024 | 2.67% |
Dr. Lal Path labs Ltd. INE600L01024 | 1.95% |
Gland Pharma Ltd. INE068V01023 | 1.88% |
Mankind Pharma Ltd. INE634S01028 | 1.67% |
Biocon Ltd. INE376G01013 | 1.27% |
Anthem Biosciences Ltd. INE0CZ201020 | 1.25% |
Narayana Hrudayalaya Ltd. INE410P01011 | 1.17% |
Max Healthcare Institute Ltd. INE027H01010 | 1.11% |
Rubicon Research Ltd. INE506V01022 | 0.85% |
Sagility Ltd. INE0W2G01015 | 0.54% |
Torrent Pharmaceuticals Ltd. INE685A01028 | 0.49% |
Sudeep Pharma Ltd. INE0QPI01025 | 0.44% |
Deepak Nitrite Ltd. INE288B01029 | 0.43% |
Neogen Chemicals Ltd. INE136S01016 | 0.42% |
Wockhardt Ltd. INE049B01025 | 0.09% |
Syngene International Ltd. INE398R01022 | 0.00% |
| Security | % NAV |
|---|---|
Mirae Asset Liquid Fund-Direct Plan-Growth INF769K01CM1 | 0.01% |
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Compare with Similar Funds
Investment Objective
Mirae Asset Healthcare Fund -Regular Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Mirae Asset Healthcare Fund -Regular Growth is a Sectoral / Thematic mutual fund offered by Mirae Asset Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹2,756 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 1.93%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations